MM23-01b

Main Content

Real World Outcomes of Older Adults and Frail Patients with Relapse/Refractory Multiple Myeloma Receiving Idecabtagene Vicleucel

Study #: MM23-01b

Study Status: Published

Presentation(s)

2024, Tandem (Poster)

Outcomes of older adults and frail patients receiving idecabtagene vicleucel: a CIBMTR study.

Citation

Akhtar OS, Oloyede T, Brazauskas R, Afrough A, Hashmi H, Sidana S, Ahmed N, Bye M, Hansen DK, Ferreri CJ, Dhakal B, Dhanda DS, Harrison MJ, Kitali A, Landau HJ, Mirza A, Patel J, Patwardhan P, Qazilbash MH, Patel KK, Nishihori T, Ganguly S, Gowda L, Anderson LD, Pasquini MC, Usmani SZ, Freeman CL.

Blood Advances. 2025, Apr 08: 9(7): 9(7):1587-1592. doi: 10.1182/bloodadvances.2024014970. Epub 2024, Dec 30. PMCID:PMC11986210.

PubMed

PMID: 39786391

Abstract